Lenalidomide as a Potent Inducer of Graft Versus Leukemia Effect in Patients with Hematologic Malignancies at High Risk of Relapse Post Allogeneic Stem Cell Transplant

Indian J Hematol Blood Transfus. 2021 Jul;37(3):500-502. doi: 10.1007/s12288-020-01362-0. Epub 2020 Oct 7.
No abstract available